How do you count polypharmacy? By the number of active ingredients or unique products? We measured it, there’s a difference and it is significant! Full manuscript now available at @IntJClinPharm https://t.co/qWyeDNmyEr
@AmyTPage@smhoski@IMPACTDeakin @deakinresearch @UWA_SAH
How do you define polypharmacy? Prevalence among older adults varied by 27% depending on the counting method and the types of medicines included.
New research here: https://t.co/qWyeDNmyEr
People who use combination medicines may or may not be captured as having #polypharmacy depending on whether the active ingredients in each product are considered.
Read more about measuring polypharmacy in our new publication: https://t.co/qWyeDNn6tZ
A new paper by @georgieblee looked at how we define polypharmacy. She compared different approaches commonly used in research finding polypharmacy prevalence estimates varied by up to 27% between different methods, https://t.co/0SYKmRTiZ1
Deprescribing for older people in hospital followed up for 12 months was tested in the AusTAPER study. We showed that a structured, collaborative medication review can reduce meds and save costs with no change to health outcomes. #Deprescribing
https://t.co/GNXaqIfrs6
A new systematic review includes 286 papers that evaluate the impact of #deprescribing in older people, focusing on the outcomes of discontinuing unnecessary medications. https://t.co/cwG4dVKH4d
@KennyPharmPhD@cdbeer Amanda Quek @drhurwitz87@AmyTPage
#Pharmacists are ready to do more in #agedcare to support #medicationsafety. Our survey showed pharmacists are interested and feel prepared to work onsite at both a resident and system level to support residents, families, and staff. https://t.co/wzu4QTVbAn
Effect of antivirals for COVID-19 on the mortality of older adults dispensed treatment with lithium, antipsychotics, antidepressants, anxiolytics and hypnotics now published in ustralian & New Zealand Journal of Psychiatry and is available at https://t.co/QCuX3pr5gg
‘What pharmacist activities do our colleagues perceive to be most valuable?’ - https://t.co/xVLJsUiKna
Read the full paper open access here: https://t.co/C4npC2B1lJ
@AJPEditor@_kmlee@AmyTPage@MichaelaNeuro
Our health economic analysis of a deprescribing RCT in residential aged care finds it could save between $1m and $16m annually if rolled out across the country
https://t.co/rHEzcNlZpJ
Theoretical Underpinnings of a Model to Reduce Polypharmacy and Its Negative Health Effects: Introducing the Team Approach to Polypharmacy Evaluation and Reduction (TAPER)
https://t.co/Um1lRknkxx
Lithium Dispensed for Adults Aged ≥ 50 Years Between 2012 and 2021: Analyses of a 10% Sample of the Australian Pharmaceutical Benefits Scheme
https://t.co/VF0DFNDoCl
Health morbidities associated with the dispensing of lithium to males and females: Cross-sectional analysis of the 10 % Pharmaceutical Benefits Scheme sample for 2022 https://t.co/7WZqq92Cv6
Dispensing of antineoplastic medications and their impact on the dispensing of anti-dementia drugs for adults aged ≥60 years: A cohort study
https://t.co/y4uuLaSmt9